Sweden’s Uppsala and Shanghai to cooperate in life science
Sweden’s Uppsala and Shanghai to cooperate in life science
10:11, March 19, 2010 
Email | Print | Subscribe | Comments | Forum 
Sweden’s Uppsala BIO and Uppsala Innovation Centre, UIC, have recently signed a cooperation agreement with Shanghai Zhangjiang Biotech & Pharmaceutical Base Development Company (ZJBPB) for Shanghai Zhangjiang Hi-Tech Science Park, according to a statement issued by UIC, which is located in the north of Stockholm.
The cooperation aims at supporting innovation companies within life science, in Uppsala and in Shanghai, to establish on the Chinese and European markets respectively, the statement said.
The cooperation agreement with the technology park in Shanghai offers Uppsala's life science companies access to the technology park's infrastructure and advisers under the same conditions as those offered to the local Chinese companies.
“We know how valuable it is to have a reliable local partner who knows the local market and can open the right doors to introduce a new technology in a new market,” said Erik Forsberg from Uppsala BIO.
“We are therefore delighted that we now have this agreement with Shanghai, which we believe will save considerable time and money for Uppsala's life science companies.”
It will be a win-win situation according to Wang Lanzhong, General Manager of ZJBPB.
“ Zhangjiang Pharma Park hosts the largest R&D cluster of life sciences in China with a focus on innovative biotechs. The collaboration between Zhangjiang and Uppsala will help companies from both sides on a soft landing in each other’s market, we will also be pleased to exchange information on other issues such as incubator management.”
Per Bengtsson, UIC's CEO said that Chinese market is attractive, but also difficult.
“China is a market that is growing strongly, but that is also regarded as ‘difficult’. We believe that the ZJBPB and Shanghai Zhangjiang Hi-Tech Science Park could be the partners who will make the way to the Chinese market a little easier and a bit safer for Uppsala's life science companies.”
In addition to support for the Uppsala-businesses looking to establish themselves in China, Uppsala also offers to introduce life science companies from Shanghai who want to establish operations in Europe, and the parties intend to help each other with general information on each market.
“In Uppsala and Stockholm we have a unique collection of expertise on regulatory issues and market knowledge, which may be of great value to Chinese companies seeking new markets, said Erik Forsberg, “ We encourage Chinese firms to perceive our region as the entrance to Europe, and there is also a great chance that some of them choose to establish their European operations here.”
Meanwhile, Wang Lanzhong said he also look forward to having European companies establishing their business operations for the Chinese market in Shanghai.
“We are impressed with the expertise level of the Uppsala based companies that we have been presented with so far, and they seem well prepared for transition into the Chinese market,” Wang said.
By Xuefei Chen, People’s Daily Online reporter in Stockholm, xuefeic@yahoo.com
The cooperation aims at supporting innovation companies within life science, in Uppsala and in Shanghai, to establish on the Chinese and European markets respectively, the statement said.
The cooperation agreement with the technology park in Shanghai offers Uppsala's life science companies access to the technology park's infrastructure and advisers under the same conditions as those offered to the local Chinese companies.
“We know how valuable it is to have a reliable local partner who knows the local market and can open the right doors to introduce a new technology in a new market,” said Erik Forsberg from Uppsala BIO.
“We are therefore delighted that we now have this agreement with Shanghai, which we believe will save considerable time and money for Uppsala's life science companies.”
It will be a win-win situation according to Wang Lanzhong, General Manager of ZJBPB.
“ Zhangjiang Pharma Park hosts the largest R&D cluster of life sciences in China with a focus on innovative biotechs. The collaboration between Zhangjiang and Uppsala will help companies from both sides on a soft landing in each other’s market, we will also be pleased to exchange information on other issues such as incubator management.”
Per Bengtsson, UIC's CEO said that Chinese market is attractive, but also difficult.
“China is a market that is growing strongly, but that is also regarded as ‘difficult’. We believe that the ZJBPB and Shanghai Zhangjiang Hi-Tech Science Park could be the partners who will make the way to the Chinese market a little easier and a bit safer for Uppsala's life science companies.”
In addition to support for the Uppsala-businesses looking to establish themselves in China, Uppsala also offers to introduce life science companies from Shanghai who want to establish operations in Europe, and the parties intend to help each other with general information on each market.
“In Uppsala and Stockholm we have a unique collection of expertise on regulatory issues and market knowledge, which may be of great value to Chinese companies seeking new markets, said Erik Forsberg, “ We encourage Chinese firms to perceive our region as the entrance to Europe, and there is also a great chance that some of them choose to establish their European operations here.”
Meanwhile, Wang Lanzhong said he also look forward to having European companies establishing their business operations for the Chinese market in Shanghai.
“We are impressed with the expertise level of the Uppsala based companies that we have been presented with so far, and they seem well prepared for transition into the Chinese market,” Wang said.
By Xuefei Chen, People’s Daily Online reporter in Stockholm, xuefeic@yahoo.com
Special Coverage
Major headlines
Editor's Pick
Most Popular
Hot Forum Dicussion
